Format

Send to

Choose Destination
Oncol Rep. 2015 Apr;33(4):2052-60. doi: 10.3892/or.2015.3771. Epub 2015 Jan 29.

Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.

Author information

1
Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, CA 94115, USA.
2
Department of Surgery, Division of Thoracic Surgery, Nippon Medical School, Tokyo 113‑8602, Japan.
3
School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China.

Abstract

Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that has a poor prognosis, limited treatment options, and a worldwide incidence that is expected to increase in the next decade. We evaluated Wnt7A expression in 50 surgically resected tumor specimens using quantitative PCR. The expression values, were assessed by clinicopathological factors and K-M and Cox's regression with OS. The mean level of Wnt7A expression had a significant correlation with International Mesothelioma Interest Group (IMIG) stage (P<0.034), gender, smoking history and ethnicity, respectively (P=0.020, P=0.014, P=0.039). In the univariate analysis, low Wnt7A expression was a significant negative factor for overall survival (P=0.043, HR=2.30). However, multivariate Cox's regression revealed no significant factors for overall survival (low Wnt7A: P=0.051, HR=2.283; non-epithelioid subtype: P=0.050, HR=2.898). In patients with epithelioid tumors, those with low Wnt7A expression had significantly worse prognosis (P=0.019, HR=2.98). In patients with epithelioid tumors, females had significantly better prognosis than males (P=0.035). In patients who did not have neoadjuvant chemotherapy, prognosis was significantly more favorable for patients with high Wnt7A expression than for those with low Wnt7A expression (P=0.031). Among the patients with low Wnt7A-expressing tumors, those who received neoadjuvant chemotherapy had better prognosis than those who did not (P=0.024). The results of our study suggest that Wnt7A expression is a putative prognostic factor and a predictor of chemosensitivity.

PMID:
25632963
PMCID:
PMC4358089
DOI:
10.3892/or.2015.3771
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Spandidos Publications Icon for PubMed Central
Loading ...
Support Center